Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Dextroamphetamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 22 USDMF, 3 CEP/COS, 17 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

43 Drugs in Development

43 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

535 FDF Dossiers, 429 FDA Orange Book, 40 Europe, 30 Canada, 1 Australia, 3 South Africa, 32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE, SUSPENSION, EXTENDED RELEASE;ORAL - 2MG/ML;EQ 0.5MG BASE/ML, TABLET, EXTENDED RELEASE;ORAL - 12MG;EQ 3MG BASE, TABLET, EXTENDED RELEASE;ORAL - 16MG;EQ 4MG BASE, TABLET, EXTENDED RELEASE;ORAL - 4MG;EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - 8MG;EQ 2MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG, CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 13 DKSH, 2 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 21 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 33 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 45 Controlled & Modified Release, 40 Thickeners and Stabilizers, 39 Direct Compression, 37 Solubilizers, 36 Taste Masking, 34 Disintegrants & Superdisintegrants, 33 Granulation, 23 Parenteral, 23 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 20 Topical, 18 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 110 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

12 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

102 US Patents, 4 US Exclusivities

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	Cambrex Corporation	U.S.A	CAMBREX CHARLES CITY, INC. Charles City US	R0-CEP 2021-478 - Rev 00	Dexamfetamine sulfate	2023-06-15	Valid	Chemical		2752
31/10/2025	Chr. Olesen Synthesis A.S	Denmark	CHR. OLESEN SYNTHESIS A/S Hvidovre DK	CEP 2019-097 - Rev 01	Dexamfetamine sulfate	2025-01-03	Valid	Chemical		2752

Dextroamphetamine

Dextroamphetamine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

22 USDMF

3 CEP/COS

17 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

43 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

535 FDF Dossiers

429 FDA Orange Book

40 Europe

30 Canada

1 Australia

3 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG

CAPSULE, EXTENDED RELEASE;ORAL - 15MG

CAPSULE, EXTENDED RELEASE;ORAL - 5MG

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE

SUSPENSION, EXTENDED RELEASE;ORAL - 2MG/ML;EQ 0.5MG BASE/ML

TABLET, EXTENDED RELEASE;ORAL - 12MG;EQ 3MG BASE

TABLET, EXTENDED RELEASE;ORAL - 16MG;EQ 4MG BASE

TABLET, EXTENDED RELEASE;ORAL - 4MG;EQ 1MG BASE

TABLET, EXTENDED RELEASE;ORAL - 8MG;EQ 2MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG

CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG

CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG

CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG

CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

9 Evonik

6 Rochem International Inc

19 SPI Pharma

13 DKSH

2 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

10 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 Bioplus Life Sciences

2 CD Formulation

21 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

12 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel